J. Sobel and . Botulism, Botulism, Clinical Infectious Diseases, vol.41, issue.8, pp.1167-1173, 2005.
DOI : 10.1086/444507

Y. Fujinaga, Y. Sugawara, and T. Matsumura, Uptake of Botulinum Neurotoxin in the Intestine, Curr Top Microbiol Immunol, vol.364, pp.45-59, 2013.
DOI : 10.1007/978-3-662-45790-0_3

A. Wheeler and H. Smith, Botulinum toxins: Mechanisms of action, antinociception and clinical applications, Toxicology, vol.306, pp.124-146, 2013.
DOI : 10.1016/j.tox.2013.02.006

J. Weber, R. Hibbs, A. Darwish, B. Mishu, A. Corwin et al., A Massive Outbreak of Type E Botulism Associated with Traditional Salted Fish in Cairo, Journal of Infectious Diseases, vol.167, issue.2, pp.451-454, 1993.
DOI : 10.1093/infdis/167.2.451

R. Hibbs, J. Weber, A. Corwin, B. Allos, A. El-rehim et al., Experience with the Use of an Investigational F(ab')2 Heptavalent Botulism Immune Globulin of Equine Origin During an Outbreak of Type E Botulism in Egypt, Clinical Infectious Diseases, vol.23, issue.2, pp.337-340, 1996.
DOI : 10.1093/clinids/23.2.337

K. Jalava, K. Selby, A. Pihlajasaari, E. Kolho, E. Dahlsten et al., Two cases of food-borne botulism in Finland caused by conserved olives, Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull, vol.16, 2011.

J. Pingeon, C. Vanbockstael, M. Popoff, L. King, B. Deschamps et al., Two outbreaks of botulism associated with consumption of green olive paste, France, Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull, vol.16, 2011.

B. Raphael, T. Shirey, C. Lúquez, and S. Maslanka, Distinguishing highly-related outbreak-associated Clostridium botulinum type A(B) strains, BMC Microbiology, vol.14, issue.1, p.25031122, 2014.
DOI : 10.1186/1471-2180-14-192

A. Gupta, C. Sumner, M. Castor, S. Maslanka, and J. Sobel, Adult botulism type F in the United States, 1981-2002, Neurology, vol.65, issue.11, pp.1694-1700, 1981.
DOI : 10.1212/01.wnl.0000187127.92446.4c

S. Arnon, R. Schechter, T. Inglesby, D. Henderson, J. Bartlett et al., Botulinum Toxin as a Biological Weapon, JAMA, vol.285, issue.8, pp.1059-1070, 2001.
DOI : 10.1001/jama.285.8.1059

J. Froude, B. Stiles, T. Pelat, and P. Thullier, Antibodies for biodefense, mAbs, vol.2, issue.6, pp.517-527, 2011.
DOI : 10.1186/1472-6750-8-66

G. Bozheyeva, Y. Kunakbayev, and D. Yeleukenov, Former Soviet Biological Weapons Facilities in Kazakhstan: Past, Present, and Future, Montrerey Inst Int Stud.Occasional Paper, issue.1, 1999.

W. Broad, . Sowing, and . Death, How Japan Germ Terror Alerted World. The New York Times Available: http://www.nytimes.com/1998/05/26/world/sowing-death-a-special- report-how-japan-germ-terror-alerted-world.html, A special report, 1998.

L. Wein and Y. Liu, Analyzing a bioterror attack on the food supply: The case of botulinum toxin in milk, Proceedings of the National Academy of Sciences, vol.102, issue.28, pp.9984-9989, 2005.
DOI : 10.1073/pnas.0408526102

B. Horowitz, E. Type, and . Botulism, Type E botulism, Clinical Toxicology, vol.49, issue.9, pp.880-895, 2010.
DOI : 10.1111/j.1442-2026.1998.tb00624.x

D. Gill, Bacterial toxins: a table of lethal amounts, Microbiol Rev, vol.46, pp.86-94, 1982.

C. Mazuet, J. Sautereau, C. Legeay, C. Bouchier, P. Bouvet et al., An Atypical Outbreak of Food-Borne Botulism Due to Clostridium botulinum Types B and E from Ham, Journal of Clinical Microbiology, vol.53, issue.2, pp.722-726, 2015.
DOI : 10.1128/JCM.02942-14

G. Schiavo, M. Matteoli, and C. Montecucco, Neurotoxins affecting neuroexocytosis, Physiol Rev, vol.80, pp.717-766, 2000.

A. Fischer, C. Garcia-rodriguez, I. Geren, J. Lou, J. Marks et al., Molecular Architecture of Botulinum Neurotoxin E Revealed by Single Particle Electron Microscopy, Journal of Biological Chemistry, vol.283, issue.7, pp.3997-4003, 2008.
DOI : 10.1074/jbc.M707917200

R. Kukreja, S. Sharma, and B. Singh, Molecular Basis of Activation of Endopeptidase Activity of Botulinum Neurotoxin Type E, Biochemistry, vol.49, issue.11, pp.2510-2519, 2010.
DOI : 10.1021/bi902096r

F. Tonello, S. Morante, O. Rossetto, G. Schiavo, and C. Montecucco, Tetanus and Botulism Neurotoxins, Adv Exp Med Biol, vol.389, pp.251-260, 1996.
DOI : 10.1007/978-1-4613-0335-0_32

D. Dressler, Botulinum toxin therapy: its use for neurological disorders of the autonomic nervous system, Journal of Neurology, vol.16, issue.Suppl 1, pp.701-713, 2013.
DOI : 10.1007/s00415-012-6615-2

E. Lim and R. Seet, Use of botulinum toxin in the neurology clinic, Nature Reviews Neurology, vol.19, issue.11, pp.624-636, 2010.
DOI : 10.1038/nrneurol.2010.149

S. Long, Infant Botulism and Treatment With BIG-IV (BabyBIG??), The Pediatric Infectious Disease Journal, vol.26, issue.3, pp.261-262, 2007.
DOI : 10.1097/01.inf.0000256442.06231.17

S. Arnon, R. Schechter, S. Maslanka, N. Jewell, and C. Hatheway, Human Botulism Immune Globulin for the Treatment of Infant Botulism, New England Journal of Medicine, vol.354, issue.5, pp.462-471, 2006.
DOI : 10.1056/NEJMoa051926

R. Black and R. Gunn, Hypersensitivity reactions associated with botulinal antitoxin, The American Journal of Medicine, vol.69, issue.4, pp.567-570, 1980.
DOI : 10.1016/0002-9343(80)90469-6

T. Smith, J. Lou, I. Geren, C. Forsyth, R. Tsai et al., Sequence Variation within Botulinum Neurotoxin Serotypes Impacts Antibody Binding and Neutralization, Infection and Immunity, vol.73, issue.9, pp.5450-5457, 2005.
DOI : 10.1128/IAI.73.9.5450-5457.2005

P. Thullier, S. Chahboun, and T. Pelat, ) immunoglobulin germline V regions and its implications for antibody engineering, mAbs, vol.2, issue.5, pp.528-538, 2010.
DOI : 10.1126/science.1139247

M. Schütte, P. Thullier, T. Pelat, X. Wezler, P. Rosenstock et al., Identification of a Putative Crf Splice Variant and Generation of Recombinant Antibodies for the Specific Detection of Aspergillus fumigatus, PLoS ONE, vol.202, issue.8, 2009.
DOI : 10.1371/journal.pone.0006625.t003

B. Hülseweh, T. Rülker, T. Pelat, C. Langermann, A. Frenzel et al., Human-like antibodies neutralizing Western equine encephalitis virus, mAbs, vol.6, pp.718-727, 2014.

T. Rülker, L. Voß, P. Thullier, O. Brien, L. Pelat et al., Isolation and Characterisation of a Human-Like Antibody Fragment (scFv) That Inactivates VEEV In Vitro and In Vivo, PLoS ONE, vol.384, issue.4, p.22666347, 2012.
DOI : 10.1371/journal.pone.0037242.g005

S. Chassagne, E. Laffly, E. Drouet, F. Hérodin, M. Lefranc et al., A high-affinity macaque antibody Fab with human-like framework regions obtained from a small phage display immune library, Molecular Immunology, vol.41, issue.5, pp.539-546, 2004.
DOI : 10.1016/j.molimm.2004.03.040

T. Pelat, M. Hust, M. Hale, M. Lefranc, S. Dübel et al., Isolation of a human-like antibody fragment (scFv) that neutralizes ricin biological activity, BMC Biotechnology, vol.9, issue.1, 2009.
DOI : 10.1186/1472-6750-9-60
URL : https://hal.archives-ouvertes.fr/hal-00410069

E. Laffly, L. Danjou, F. Condemine, D. Vidal, E. Drouet et al., Selection of a Macaque Fab with Framework Regions Like Those in Humans, High Affinity, and Ability To Neutralize the Protective Antigen (PA) of Bacillus anthracis by Binding to the Segment of PA between Residues 686 and 694, Antimicrobial Agents and Chemotherapy, vol.49, issue.8, pp.3414-3420, 2005.
DOI : 10.1128/AAC.49.8.3414-3420.2005

T. Pelat, M. Hust, E. Laffly, F. Condemine, C. Bottex et al., High-Affinity, Human Antibody-Like Antibody Fragment (Single-Chain Variable Fragment) Neutralizing the Lethal Factor (LF) of Bacillus anthracis by Inhibiting Protective Antigen-LF Complex Formation, Antimicrobial Agents and Chemotherapy, vol.51, issue.8, pp.2758-2764, 2007.
DOI : 10.1128/AAC.01528-06

S. Miethe, C. Rasetti-escargueil, Y. Liu, S. Chahboun, T. Pelat et al., Development of neutralizing scFv-Fc against botulinum neurotoxin A light chain from a macaque immune library, mAbs, vol.57, issue.2, pp.446-459, 2014.
DOI : 10.1038/2338

T. Kubota, T. Watanabe, N. Yokosawa, K. Tsuzuki, T. Indoh et al., Epitope regions in the heavy chain of Clostridium botulinum type E neurotoxin recognized by monoclonal antibodies, Appl Environ Microbiol, vol.63, pp.1214-1218, 1997.

C. Garcia-rodriguez, I. Geren, J. Lou, F. Conrad, C. Forsyth et al., Neutralizing human monoclonal antibodies binding multiple serotypes of botulinum neurotoxin, Protein Engineering Design and Selection, vol.24, issue.3, pp.321-331, 2011.
DOI : 10.1093/protein/gzq111

Q. Meng, C. Garcia-rodriguez, G. Manzanarez, M. Silberg, F. Conrad et al., Engineered domain-based assays to identify individual antibodies in oligoclonal combinations targeting the same protein, Analytical Biochemistry, vol.430, issue.2, p.22922799, 2012.
DOI : 10.1016/j.ab.2012.08.005

R. National and . Council, Guide for the Care and Use of Laboratory Animals. Eight Edition, 2011.

T. Pelat, M. Hust, and P. Thullier, Obtention and Engineering of Non-Human Primate (NHP) Antibodies for Therapeutics, Mini-Reviews in Medicinal Chemistry, vol.9, issue.14, pp.1633-1638, 2009.
DOI : 10.2174/138955709791012283

J. Kügler, S. Wilke, D. Meier, F. Tomszak, A. Frenzel et al., Generation and analysis of the improved human HAL9/10 antibody phage display libraries, BMC Biotechnology, vol.15, issue.1, p.25888378, 2015.
DOI : 10.1006/clin.1997.4388

P. Carter, H. Bedouelle, and G. Winter, Improved oligonudeotide site-directed rautagenesis using M13 vectors, Nucleic Acids Research, vol.13, issue.12, pp.4431-4443, 1985.
DOI : 10.1093/nar/13.12.4431

V. Jäger, K. Büssow, A. Wagner, S. Weber, M. Hust et al., High level transient production of recombinant antibodies and antibody fusion proteins in HEK293 cells, BMC Biotechnol, vol.13, p.23802841, 2013.

P. Schuck and A. Minton, Analysis of Mass Transport-Limited Binding Kinetics in Evanescent Wave Biosensors, Analytical Biochemistry, vol.240, issue.2, pp.262-272, 1996.
DOI : 10.1006/abio.1996.0356

R. Jones, M. Ochiai, Y. Liu, T. Ekong, and D. Sesardic, Development of improved SNAP25 endopeptidase immuno-assays for botulinum type A and E toxins, Journal of Immunological Methods, vol.329, issue.1-2, pp.92-101, 2008.
DOI : 10.1016/j.jim.2007.09.014

S. Chahboun, M. Hust, Y. Liu, T. Pelat, S. Miethe et al., Isolation of a nanomolar scFv inhibiting the endopeptidase activity of botulinum toxin A, by single-round panning of an immune phage-displayed library of macaque origin, BMC Biotechnology, vol.11, issue.1, p.22111995, 2011.
DOI : 10.1186/1472-6750-11-113

C. Rasetti-escargueil, R. Jones, Y. Liu, and D. Sesardic, Measurement of botulinum types A, B and E neurotoxicity using the phrenic nerve???hemidiaphragm: Improved precision with in-bred mice, Toxicon, vol.53, issue.5, pp.503-511, 2009.
DOI : 10.1016/j.toxicon.2009.01.019

C. Rasetti-escargueil, Y. Liu, P. Rigsby, R. Jones, and D. Sesardic, Phrenic nerve-hemidiaphragm as a highly sensitive replacement assay for determination of functional botulinum toxin antibodies, Toxicon, vol.57, issue.7-8, pp.1008-1016, 2011.
DOI : 10.1016/j.toxicon.2011.04.003

J. Froude, P. Thullier, and T. Pelat, Antibodies against Anthrax: Mechanisms of Action and Clinical Applications, Toxins, vol.3, issue.12, pp.1433-1452, 2011.
DOI : 10.3390/toxins3111433

P. Thullier, O. Huish, T. Pelat, and A. Martin, The Humanness of Macaque Antibody Sequences, Journal of Molecular Biology, vol.396, issue.5, pp.1439-1450, 2010.
DOI : 10.1016/j.jmb.2009.12.041

P. Thullier, A. A. Mathieu, J. Behrens, C. Pellequer, J. Pelat et al., Mapping the Epitopes of a Neutralizing Antibody Fragment Directed against the Lethal Factor of Bacillus anthracis and Cross-Reacting with the Homologous Edema Factor, PLoS ONE, vol.2, issue.5, p.23741517, 2013.
DOI : 10.1371/journal.pone.0065855.t002

A. Avril, J. Froude, J. Mathieu, T. Pelat, and P. Thullier, Isolation of Antibodies From Non-Human Primates for Clinical Use, Current Drug Discovery Technologies, vol.11, issue.1, pp.20-27, 2014.
DOI : 10.2174/15701638113109990030

W. Hwang and J. Foote, Immunogenicity of engineered antibodies. Methods San Diego Calif, 2005.

P. Tan, D. Mitchell, T. Buss, M. Holmes, C. Anasetti et al., "Superhumanized" Antibodies: Reduction of Immunogenic Potential by Complementarity-Determining Region Grafting with Human Germline Sequences: Application to an Anti-CD28, The Journal of Immunology, vol.169, issue.2, pp.1119-1125, 1950.
DOI : 10.4049/jimmunol.169.2.1119

M. Hust, T. Meyer, B. Voedisch, T. Rülker, H. Thie et al., A human scFv antibody generation pipeline for proteome research, Journal of Biotechnology, vol.152, issue.4, p.20883731, 2011.
DOI : 10.1016/j.jbiotec.2010.09.945

L. Rosenwasser, W. Busse, R. Lizambri, T. Olejnik, and M. Totoritis, Allergic asthma and an anti-CD23 mAb (IDEC-152) Results of a phase I, single-dose, dose-escalating clinical trial, Journal of Allergy and Clinical Immunology, vol.112, issue.3, pp.563-570, 2003.
DOI : 10.1016/S0091-6749(03)01861-X

N. Pathan, A. Zou, P. Chu, D. Wynne, B. Leigh et al., Lumiliximab (IDEC?152), an anti-CD23 antibody , induces apoptosis in vitro and in vivo in CLL cells, AACR Meet Abstr, p.163, 2004.

T. Pelat and P. Thullier, Non-human primate immune libraries combined with germline humanization, mAbs, vol.146, issue.4, pp.377-381, 2009.
DOI : 10.1016/j.critrevonc.2007.04.011

T. Pelat, H. Bedouelle, A. Rees, S. Crennell, M. Lefranc et al., Germline Humanization of a Non-human Primate Antibody that Neutralizes the Anthrax Toxin, by in Vitro and in Silico Engineering, Journal of Molecular Biology, vol.384, issue.5, pp.1400-1407, 2008.
DOI : 10.1016/j.jmb.2008.10.033
URL : https://hal.archives-ouvertes.fr/hal-00345933